Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: initial (387), budding (11), early (483)

Dietary advice for jejunocolic anastomosis - patient information

Description: This factsheet explains jejunocolic anastomosis and the dietary changes you may need to make because of this.
Url: /Media/UHS-website-2019/Patientinformation/Digestionandurinaryhealth/Dietary-advice-for-jejunocolic-anastomosis-3195-PIL.pdf

Immunotherapy - patient information

Description: This factsheet explains what immunotherapy is, how it works and what the possible side effects are.
Url: /Media/UHS-website-2019/Patientinformation/Cancercare/Immunotherapy-2698-PIL.pdf

Angiogram and angioplasty - patient information

Description: Information about angiogram to assess the blood flow into your leg and angioplasty to improve the blood flow.
Url: /Media/UHS-website-2019/Patientinformation/Cardiovascular-and-thoracic/Angiogram-and-angioplasty-1655-PIL.pdf

Total body irradiation (TBI) - patient information

Description: This factsheet explains what to expect at your TBI treatment appointments.
Url: /Media/UHS-website-2019/Patientinformation/Cancercare/Total-body-irradiation-TBI-1332-PIL.pdf

Apalutamide v1

Description: Chemotherapy Protocol PROSTATE APALUTAMIDE Regimen  Prostate cancer Indication  Apalutamide is recommended for non-metastatic prostate
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Prostatecancer/Apalutamide-v1.pdf

Docetaxel-Nintedanib v1

Description: Chemotherapy Protocol NSCLC CANCER DOCETAXEL-NINTEDANIB Regimen NSCLC – Docetaxel-Nintedanib Indication Advanced or metastatic NSCLC of adenocarcinoma origin that has progressed
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Docetaxel-Nintedanib-v1.pdf

Docetaxel

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) DOCETAXEL (75) Regimen NSCLC – Docetaxel (75) Indication Second line therapy of stage IIIB
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Docetaxelver12.pdf

Cisplatin Doxorubicin Methotrexate Vinblastine (accelerated) ver1.1

Description: Chemotherapy Protocol BLADDER CISPLATIN-DOXORUBICIN-METHOTREXATE-VINBLASTINE (Accelerated MVAC) Regimen Bladder-Cisplatin-Doxorubicin-Methotrexate-Vinblastine (AccMVAC) Indication First or second line
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Cisplatin-Doxorubicin-Methotrexate-Vinblastine-accelerated-ver1.1.pdf

Docetaxel (75)-Prednisolone ver1.2

Description: Chemotherapy Protocol PROSTATE DOCETAXEL(75)-PREDNISOLONE Regimen Prostate-Docetaxel (75)-Prednisolone Indication Advanced castrate resistant prostate cancer Performance status 0, 1
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Prostatecancer/Docetaxel-75-Prednisolone-ver1.2.pdf

Docetaxel (75) Prednisolone (6 cycles)) Ver1

Description: Chemotherapy Protocol PROSTATE DOCETAXEL(75)-PREDNISOLONE (6 cycles) Regimen Prostate-Docetaxel (75)-Prednisolone (6 cycles) Indication First line treatment of prostate
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Prostatecancer/Docetaxel-75-Prednisolone-6-cycles-Ver1.pdf

561 to 570 of 1000

Previous … 55 56 57 58 59 … Next